Compare ARVN & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARVN | LEGH |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 600.2M | 691.6M |
| IPO Year | 2018 | 2018 |
| Metric | ARVN | LEGH |
|---|---|---|
| Price | $7.26 | $27.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 2 |
| Target Price | $13.93 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 646.8K | 59.3K |
| Earning Date | 11-04-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.84 | N/A |
| EPS | ★ 1.70 | 1.44 |
| Revenue | ★ $262,600,000.00 | $164,567,000.00 |
| Revenue This Year | $12.76 | $23.39 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $4.54 | $19.62 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.74 | $18.29 |
| 52 Week High | $14.22 | $31.34 |
| Indicator | ARVN | LEGH |
|---|---|---|
| Relative Strength Index (RSI) | 43.63 | 50.96 |
| Support Level | $6.74 | $25.03 |
| Resistance Level | $7.74 | $30.04 |
| Average True Range (ATR) | 0.36 | 0.82 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 51.43 | 55.34 |
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
Legacy Housing Corp builds, sells, and finances manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores, and are also sold directly to manufactured home communities. The Company manufactures and provides for the transport of manufactured homes, provides wholesale financing to dealers and mobile home parks, provides retail financing to consumers, and is involved in financing and developing new manufactured home communities. The Company manufactures its mobile homes at plants in Fort Worth, Texas; Commerce, Texas; and Eatonton, Georgia. The Company also sells homes directly to consumers, through its own retail stores, and to dealers and mobile home parks.